The BCC and SIG-backed news aggregator was valued at about $550m in a round led by technology investment firm Vy Capital.
Month: July 2021
Analysis: Cybereason raises $275m
Softbank enabled the cybersecurity software provider Cybereason to secure crossover financing at a valuation likely to have exceeded $3bn. This year seems set to be a record one for the broader corporate-backed cybersecurity space, with valuations spiking up.
Daily Deal Round Up: July 16, 2021
Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.
Matthew Ball’s nine-part framework for the metaverse
Great to read Matthew Ball’s latest nine-part framework for the metaverse.
Revolut receives $800m at $33bn valuation
SoftBank Vision Fund 2 and Tiger Global Management provided the cash, increasing the mobile financial services provider’s overall funding to over $1.7bn.
Paytm prepares $2.2bn initial public offering
The corporate-backed mobile payments app’s parent company, One97 Communications, has filed to float in an offering set to include $1.1bn of existing share sales.
MS&AD Ventures boosts fund to $200m
MS&AD Holdings has put up an additional $80m for its corporate venture capital vehicle, two years after tripling its original commitment.
Imperative Care imports $260m in series D
Imperative Care boosted its total funding to at least $379m, with Ascension Ventures participating in the stroke care technology provider’s series D round.
Restar readies corporate venturing initiative
The semiconductor contract manufacturer’s Restar-SBI Innovation fund will focus on developers of digitalisation and healthcare technologies.
Imago BioSciences bags $134m in upsized IPO
Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.
Wugen wraps up $172m series B
Alexandria Venture Investments was among the participants in a series B round for Wugen, which is developing cellular therapeutics for cancer.
Netradyne accelerates to $150m series C
SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.
FedEx Express injects $100m in Delhivery
FedEx Express has provided the shipping and logistics service provider with fresh funding which will boost its pick-up and delivery services across India.
Kriya Therapeutics engineers $100m series B
Patient Square Capital led a series B round for the gene therapy developer that included existing corporate investor Dexcel Pharma.